| Application no. and date | 20740022.7 (espacenet) (Federated) (European Patent Register), 20200717 | | Patent/reg. no. and date | DK/EP 3999069, 20231011 | | Publication date | 20220525 | | Priority no. and date | EP 19186941, 20190718 | | EP pub. no. and date |
EP 3999069 20220525 | | Effective date | | | Applicant/owner | ENYO Pharma, 60 avenue Rockefeller Bioserra 1
Bâtiment B
69008 Lyon, FR | | Applicant ref. no. | | | Inventor | VONDERSCHER, Jacky, 1 avenue des Vignes
81600 SENOUILLAC, FR,
ROY, Elise, 28, avenue de l Esplanade
1012 LAUSANNE, CH,
SCALFARO, Pietro, Ob dem Biel 10
3984 FIESCH, CH,
DARTEIL, Raphaël, 48 rue Sainte Geneviève
69006 Lyon, FR | | Representative | | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 31/52 (2006.01) , A61K 38/21 (2006.01) , A61P 31/20 (2006.01) | | Title | SYNERGISTIC EFFECT OF EYP001 AND IFN FOR THE TREATMENT OF HBV INFECTION | | Int. application no. | EP2020070241 | | Int. publication no. | WO2021009333 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
